Blood pressure response with fixed-dose combination therapy: Comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis

Journal of Hypertension

Volumn 31, Issue 8, 2013, Pages 1692-1701

  Agarwal, Rajiv ^a   Weir, Matthew R ^b  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

ambulatory blood pressure monitoring; amlodipine; combination therapy; diabetes mellitus; hydrochlorothiazide; meta analysis

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS OLMESARTAN; HYDROCHLOROTHIAZIDE; OLMESARTAN;

AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; BODY MASS; CHRONIC KIDNEY DISEASE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPOTENSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84880572277     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836157be     Document Type: Article

References (18)

1. Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol 2011; 57:590-600.
2. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713-719.
3. Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, et al. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study. Ther Adv Cardiovasc Dis 2010; 4:209-221.
4. Ram CV, Sachson R, Littlejohn T, Qian C, Shojaee A, Stoakes KA, et al. Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen. Am J Cardiol 2011; 107:1346-1352.
5. Weir MR, Hsueh WA, Nesbitt SD, Littlejohn T J3rd, Graff A, Shojaee A, et al. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil +;/- hydrochlorothiazide. J Clin Hypertens (Greenwich) 2011; 13:404-412.
6. Neutel JM, Kereiakes DJ, Waverczak WF, Stoakes KA, Xu J, Shojaee A. Effects of an olmesartan medoxomil based treatment algorithm on 24-h blood pressure control in patients with hypertension and type 2 diabetes. Curr Med Res Opin 2010; 26:721-728.
7. Kereiakes DJ, Neutel J, Stoakes KA, Waverczak WF, Xu J, Shojaee A, et al. The effects of an olmesartan medoxomil-based treatment algorithm on 24-h blood pressure levels in elderly patients aged 65 and older. J Clin Hypertens (Greenwich) 2009; 11:411-421.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
9. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
10. Luft FC, Weinberger MH. Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm. Am J Clin Nutr 1997; 65:612S-617S.
11. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27:481-490.
12. Luft FC, Weinberger MH, Fineberg NS, Miller JZ, Grim CE. Effects of age on renal sodium homeostasis and its relevance to sodium sensitivity. Am J Med 1987; 82:9-15.
13. Chrysant SG, Weir MR, Weder AB, McCarron DA, Canossa-Terris M, Cohen JD, et al. There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients. Arch Intern Med 1997; 157:2489-2494.
14. Jamerson KA, Devereux R, Bakris GL, Dahlof B, Pitt B, Velazquez EJ, et al. Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-h ambulatory systolic blood pressure control. Hypertension 2011; 57:174-179.
15. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22:435-445.
16. Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2012; 381:537-545.
17. Staessen JA, Thijs L,Ohkubo T, Kikuya M, Richart T, Boggia J, et al. Thirty years of research on diagnostic and therapeutic thresholds for the selfmeasured blood pressure at home. Blood Press Monit 2008; 13:352-365.
18. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011; 57:29-38.